Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant

Authors
Kim, Jong YupKim, DeukjoonKang, Suk YounPark, Woo-KyuKim, Hyun JungJung, Myung EunSon, Eun-JungPae, Ae NimKim, JeongminLee, Jinhwa
Issue Date
2010-11-15
Publisher
Pergamon Press Ltd.
Citation
Bioorganic & Medicinal Chemistry Letters, v.20, no.22, pp.6439 - 6442
Abstract
Pyrimidine usually has good pharmacokinetic properties as a drug substance and considerable efforts have been devoted to develop pyrimidine derivatives into drug candidates. Arylpiperazine-containing pyrimidine 4-carboxamide derivatives were synthesized and evaluated for binding to serotonin receptors and transporter. Pyrimidine derivatives showed good antidepressant activity in FST (forced swimming test) animal model and also displayed no appreciable inhibitory activity against hERG channel blocking assay. Herein SAR studies of pyrimidine derivatives targeting serotonin receptors and transporter will be disclosed. (C) 2010 Elsevier Ltd. All rights reserved.
Keywords
RECEPTOR ANTAGONIST; REUPTAKE INHIBITORS; BIPOLAR DISORDER; NEUROPSYCHOLOGY; NEFAZODONE; RECEPTOR ANTAGONIST; REUPTAKE INHIBITORS; BIPOLAR DISORDER; NEUROPSYCHOLOGY; NEFAZODONE; Antidepressant; Serotonin; Piperazine; Pyrimidine
ISSN
0960-894X
URI
https://pubs.kist.re.kr/handle/201004/130927
DOI
10.1016/j.bmcl.2010.09.081
Appears in Collections:
KIST Article > 2010
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE